2023 The First Beijing-Tianjin-Hebei Pharmaceutical Innovation and Development Conference Opens in Xiong’an New Area, Hebei

[ad_1]

Great Wall Net? Jiyun Client News (Reporter Liu Kunpeng and He Zhen) On June 18, it was co-sponsored by the Hebei Provincial Pharmaceutical Association, Beijing Pharmaceutical Association, and Tianjin Pharmaceutical Association. The first Beijing-Tianjin-Hebei Pharmaceutical Innovation and Development Conference jointly directed by the Association for Science and Technology opened in Xiong’an New District.

The opening ceremony of the 2023 Beijing-Tianjin-Hebei First Pharmaceutical Innovation and Development Conference.

With the theme of “Pharmaceutical Innovation? Set Sail in Xiong’an”, the conference discusses the way of pharmaceutical innovation and participates in the grand ceremony of pharmaceutical development. The opening ceremony will be broadcast live online, and will be held in a combination of online and offline. More than 400 people, including well-known academicians, experts and scholars in the domestic pharmaceutical field, leaders of Beijing-Tianjin-Hebei regional government departments, well-known pharmaceutical companies, and experts from medical institutions, gathered together, and nearly 10,000 people participated in watching and listening online.

Yao Wenbing, vice president of China Pharmaceutical University, delivered a keynote speech.

The conference will include speeches by guests at the opening ceremony, keynote reports and nine special sessions. In the keynote report session, Bi Jingquan, member of the Standing Committee of the National Committee of the Chinese People’s Political Consultative Conference, deputy director of the Economic Committee, and executive vice chairman of the China International Economic Exchange Center, made “Boosting Market Expectations and Confidence and Promoting Innovation and Development of the Biomedical Industry”; Academician of the Chinese Academy of Engineering, Cancer Hospital of the Chinese Academy of Medical Sciences Xu Binghe, director of the National New Drug Anti-tumor Clinical Research Center, made “The Current Situation and Challenges of New Anti-tumor Drug Research and Development in China”; Yao Wenbing, Vice President of China Pharmaceutical University, made “Innovative Development of Pharmaceutical Education under the Background of Medical Education Reform”; Du Yuguang, academician and leader of the research group of the State Key Laboratory of the Chinese Academy of Sciences, gave a wonderful speech on the theme of “Traditional Chinese Medicine Polysaccharide Resource Mining and Idea Innovation”. Zhang Boli, winner of the national honorary title of “Hero of the People”, academician of the Chinese Academy of Engineering, master of traditional Chinese medicine, and honorary president of Tianjin University of Traditional Chinese Medicine, sent a video congratulatory message to the conference.

Special academic seminar site.

The nine special academic seminars were “pharmaceutical services and innovation”, “oncology drug innovation and development”, “rehabilitation and treatment after COVID-19 infection”, “prospects and high-quality development of innovative drugs”, “value and clinical application of innovative drugs” and “rational drug use”. Management and Practice, “Medical Insurance Policy Discussion”, etc., aim to form enlightening new ideas, A new method with reference value provides a pioneering exploration experience to boost the high-quality development of Beijing-Tianjin-Hebei pharmaceutical innovation.

At the opening ceremony, relevant leaders of Xiong’an New Area introduced the development policies of Xiong’an New Area, and pointed out that they hope to take this conference as an opportunity to accelerate the pace of innovation in the Beijing-Tianjin-Hebei biomedical industry and share new ideas, new technologies, and new products in the world’s biomedical industry , produce more innovative, iconic and leading achievements, promote the integration and coordinated development of the “double chain” of the Beijing-Tianjin-Hebei biomedical industry, and make new and greater contributions to a healthy China.

At the same time, this conference released the strategic cooperation agreement signed by the Chinese Pharmaceutical Association and the Hebei Science and Technology Association and the consensus on innovation and development of the pharmaceutical associations in Beijing, Tianjin and Hebei.

Representatives of pharmaceutical companies conduct cooperation and exchanges.

In addition, the conference selected 50 top 100 pharmaceutical companies at home and abroad to participate in the exhibition. Through the combination of display board text, pictures and lighting, the innovative achievements of domestic and foreign biopharmaceutical companies were displayed, and the Beijing-Tianjin-Hebei region was displayed in an all-round way. The development status and future prospects of the biomedical industry, focusing on the supply chain of the biomedical industry chain, building a platform for biomedical and big health companies, promoting business opportunities, promoting higher-level and wider exchanges and cooperation in biomedicine and big health, and promoting the Beijing-Tianjin-Hebei biological Co-construction of pharmaceutical industry ecology, sharing of resources, and sharing of research and development will help build a 100-billion-level biomedical industry cluster.

This year’s conference presents five highlights, namely, the gathering of pioneers and their contribution to the wisdom of medical innovation; the appearance of benchmarking enterprises to showcase their achievements in medical innovation; the release of strategic agreements to create a model of regional cooperation; the full chain of seminars to enhance the level of academic leadership; the launch of Xiong’an New District , to help collaborative innovation and development. These highlights will deepen the integrated development of Beijing-Tianjin-Hebei production, learning, research and use, explore the close integration of talent chains, innovation chains, and industrial chains, further promote the coordinated development of Beijing-Tianjin-Hebei and the construction of high-level biomedical innovation platforms, and accelerate Beijing-Tianjin It is hoped that the strategic emerging industries of biomedicine will supplement, extend, and strengthen the chain, and promote the transformation of biomedical scientific and technological achievements to have a positive impact.

[ad_2]

Source link